(Re)Appraising Remission in Ulcerative Colitis

被引:0
|
作者
Sood, Ajit [1 ]
Singh, Arshdeep [1 ]
Mahajan, Ramit [1 ]
Midha, Vandana [2 ]
Bernstein, Charles N. [3 ]
Rubin, David T. [4 ]
机构
[1] Dayanand Med Coll & Hosp, Dept Gastroenterol, Ludhiana, Punjab, India
[2] Dayanand Med Coll & Hosp, Dept Internal Med, Ludhiana, Punjab, India
[3] Univ Manitoba, Rady Fac Hlth Sci, IBD Clin & Res Ctr & Sect Gastroenterol, Max Rady Coll Med,Dept Med, Winnipeg, MB, Canada
[4] Univ Chicago Med, Ctr Inflammatory Bowel Dis, Chicago, IL USA
关键词
Clinical remission; endoscopic remission; inflammatory bowel disease; mucosal healing; treatment goals; ulcerative colitis; INFLAMMATORY-BOWEL-DISEASE; QUALITY-OF-LIFE; C-REACTIVE PROTEIN; HEALING MAYO 0; FECAL CALPROTECTIN; MAINTENANCE THERAPY; HISTOLOGICAL REMISSION; CLINICAL REMISSION; 5-AMINOSALICYLIC ACID; ENDOSCOPIC REMISSION;
D O I
10.1093/ibd/izac170
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
As the therapeutic targets in ulcerative colitis (UC) shift from control of symptoms to mucosal healing and prevention of disease complications like disability, colectomy, and cancer, the definition of remission has evolved. The current definition of clinical remission is variable and is determined by the clinical context in which it is being used. This results in skepticism and uncertainty about the true meaning of the term "clinical remission." In this review, the authors reexamine the definition of clinical remission and propose a novel approach to define remission in UC. Lay Summary The current definition of clinical remission in ulcerative colitis (UC) is variable and is determined by the clinical context in which it is being used. In this review, the authors reexamine the definition of clinical remission in UC and propose a novel approach to define remission based on the parameter being assessed.
引用
收藏
页码:1317 / 1326
页数:10
相关论文
共 50 条
  • [41] A review of the therapeutic management of ulcerative colitis
    Aslam, Nasar
    Lo, Sheng Wei
    Sikafi, Rafid
    Barnes, Tom
    Segal, Jonathan
    Smith, Philip J.
    Limdi, Jimmy K.
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2022, 15
  • [42] Infliximab for the treatment of pediatric ulcerative colitis
    Bradley, Gia M.
    Oliva-Hemker, Maria
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2012, 6 (06) : 659 - 665
  • [43] Inducing remission of ulcerative colitis: are clinicians better equipped than ever?
    Armuzzi, Alessandro
    Felice, Carla
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2013, 7 (02) : 95 - 97
  • [44] Prognosis of Patients with Ulcerative Colitis in Sustained Remission After Thiopurines Withdrawal
    Moreno-Rincon, Estefania
    Manuel Benitez, Jose
    Javier Serrano-Ruiz, Francisco
    Maria Vazquez-Moron, Juan
    Pallares-Manrique, Hector
    Manuel Herrera-Justiniano, Jose
    Leo-Carnerero, Eduardo
    Rosario Gomez-Garcia, Maria
    Jose Cabello-Tapia, Maria
    Castro-Fernandez, Manuel
    Rojas-Feria, Maria
    Castro-Laria, Luisa
    Argueelles-Arias, Federico
    Camargo-Camero, Raquel
    Alcain-Martinez, Guillermo
    Iglesias-Flores, Eva
    Garcia-Sanchez, Valle
    INFLAMMATORY BOWEL DISEASES, 2015, 21 (07) : 1564 - 1571
  • [45] Considering Histologic Remission in Ulcerative Colitis as a Long-Term Target
    Pavel, Christopher
    Diculescu, Mircea Mihai
    Stepan, Alex-Emilian
    Constantinescu, Gabriel
    Sandru, Vasile
    Tieranu, Cristian George
    Tomescu, Luiza
    Constantinescu, Alexandru
    Patoni, Cristina
    Plotogea, Oana-Mihaela
    Ilie, Madalina
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (01)
  • [46] 'Treat to Target' in Mild to Moderate Ulcerative Colitis: Evidence to Support this Strategy
    Dal Buono, Arianna
    Roda, Giulia
    Argollo, Marjorie
    Paridaens, Kristine
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    CURRENT DRUG TARGETS, 2021, 22 (01) : 117 - 125
  • [47] Prevalence of irritable bowel syndrome-like symptoms in ulcerative colitis patients with clinical and endoscopic evidence of remission: prospective multicenter study
    Fukuba, Nobuhiko
    Ishihara, Shunji
    Tada, Yasumasa
    Oshima, Naoki
    Moriyama, Ichiro
    Yuki, Takafumi
    Kawashima, Kousaku
    Kushiyama, Yoshinori
    Fujishiro, Hirofumi
    Kinoshita, Yoshikazu
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2014, 49 (06) : 674 - 680
  • [48] Phylogenetic Analysis of Dysbiosis in Ulcerative Colitis During Remission
    Rajilic-Stojanovic, Mirjana
    Shanahan, Fergus
    Guarner, Francisco
    de Vos, Willem M.
    INFLAMMATORY BOWEL DISEASES, 2013, 19 (03) : 481 - 488
  • [49] Safety and efficacy of Proferminto induce remission in ulcerative colitis
    Aleksander Krag
    Hans Israelsen
    Bjrn von Ryberg
    Klaus K Andersen
    Flemming Bendtsen
    World Journal of Gastroenterology, 2012, 18 (15) : 1773 - 1780
  • [50] Adalimumab treatment of anti-TNF-naive patients with ulcerative colitis: Deep remission and response factors
    Munoz-Villafranca, Carmen
    Ortiz de Zarate, Jone
    Arreba, Paz
    Higuera, Rebeca
    Gomez, Laura
    Ibanez, Sylvia
    Merino, Olga
    Munagorri, Ana
    Ogueta, Maria
    Rodriguez, Cristina
    Nantes, Oscar
    Ramirez de la Piscina, Patricia
    Rodriguez, Iago
    Bernal, Antonio
    Arevalo, Juan
    Cabriada, Jose
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (08) : 812 - 819